Table 1.
Risk factors for the development of VTE in kidney diseases
| Risk factors | References |
|---|---|
| NS and VTE | [33, 34, 35, 36] |
| MN | |
| FSGS | |
| Lupus nephritis | |
| Low albumin levels | |
| Sepsis | |
| Intravenous corticosteroid use | |
| BMI ≥30 kg/m2 | |
| AKI | |
| Female sex | |
| CKD and VTE | [43] |
| Immobilization | |
| Surgery | |
| Prothrombin G20210A | |
| Malignancy | |
| Factor V Leiden | |
| Low eGFR | |
| ESRD and VTE | [46, 47] |
| Receiving hemodialysis than patients with peritoneal dialysis | |
| Toxic nephropathy as the cause of ESRD | |
| Atrial fibrillation | |
| Female sex | |
| Kidney transplantation and VTE | [51, 53, 54] |
| Recipient female gender | |
| eGFR less than 30 mL/min/1.73 m2 | |
| Right kidneys | |
| The ADPKD group |
VTE, venous thromboembolism; MN, membranous nephropathy; FSGS, focal segmental glomerular sclerosis; BMI, body mass index; AKI, acute kidney injury; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease; ADPKD, autosomal dominant polycystic kidney disease.